Correlation between postoperative systemic inflammatory response and prognosis in patients with advanced gastric cancer.

Authors

null

Kenji Kuroda

Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan

Kenji Kuroda , Takahiro Toyokawa , Yuichiro Miki , Mami Yoshii , Hiroaki Kasashima , Tatsunari Fukuoka , Tatsuro Tamura , Masatsune Shibutani , Shigeru Lee , Masakazu Yashiro , Kiyoshi Maeda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Other

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 411)

DOI

10.1200/JCO.2024.42.3_suppl.411

Abstract #

411

Poster Bd #

K16

Abstract Disclosures

Similar Posters

Poster

2015 Gastrointestinal Cancers Symposium

The prognostic factors and the cause of death in patients with advanced or recurrent gastric cancer.

The prognostic factors and the cause of death in patients with advanced or recurrent gastric cancer.

First Author: Sang Woo Lee

Poster

2020 Gastrointestinal Cancers Symposium

Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.

Prognostic factor of nivolumab for advanced gastric cancer patients with poor performance status patients.

First Author: Toshihiko Matsumoto

Poster

2019 Gastrointestinal Cancers Symposium

The impact of infectious complications on long-term prognosis after curative resection for gastric cancer.

The impact of infectious complications on long-term prognosis after curative resection for gastric cancer.

First Author: Yukio Maezawa

Poster

2017 Gastrointestinal Cancers Symposium

Prognostic factors of trastuzumab-based chemotherapy in patients with advanced HER2 positive gastric cancer.

Prognostic factors of trastuzumab-based chemotherapy in patients with advanced HER2 positive gastric cancer.

First Author: Shoko Marshall